BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, December 18, 2024
See today's BioWorld
Home
» Elixa, TECOS trials show no undue cardiovascular or pancreatic risks
To read the full story,
subscribe
or
sign in
.
Elixa, TECOS trials show no undue cardiovascular or pancreatic risks
June 9, 2015
By
Anette Breindl
No Comments
BOSTON – Overall, physicians and patients can take heart from the results of two cardiovascular outcomes trials presented at the 75th annual meeting of the American Diabetes Association.
BioWorld